A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer
Recruiting
N/A
Interventional Study
Anatomic Stage I Breast Cancer AJCC v8
Anatomic Stage II Breast Cancer AJCC v8
Anatomic Stage III Breast Cancer AJCC v8
Anatomic Stage IV Breast Cancer AJCC v8
Breast Carcinoma
Breast Mixed Epithelial/Mesenchymal Metaplastic Carcinoma
Endometrial Carcinoma
Malignant Female Reproductive System Neoplasm
Ovarian Carcinoma
Ovarian Carcinosarcoma
Stage III Cervical Cancer AJCC v8
Stage III Vaginal Cancer AJCC v8
Stage III Vulvar Cancer AJCC v8
Stage IV Cervical Cancer AJCC v8
Stage IV Vaginal Cancer AJCC v8
Stage IV Vulvar Cancer AJCC v8
Triple-Negative Breast Carcinoma
Uterine Corpus Carcinosarcoma
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Female
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 126 (estimated)
- Sponsor
- City of Hope Medical Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This clinical trial studies whether an intervention supported by technology (blended e-health intervention) works to improve fear of progression (FOP) in women with gynecologic or breast cancer. FOP is the fear patients experience from the possibility that their cancer could grow, spread, or get worse. Managing FOP is a leading unmet concern of cancer patients. High levels of FOP are associated wi…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Women with stage III or IV GYN (ovarian, endometrial, cervical, vulvar/vaginal) or breast cancer who are at least 2 months from initial diagnosis OR Women with stage I or II endometrial, ovarian, or breast cancer with carcinosarcoma histology OR Women with stage I or II triple…
Contacts
No contact information available.